日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade

肿瘤内 CD103+ CD8+ T 细胞可预测对 PD-L1 阻断疗法的反应

Banchereau, Romain; Chitre, Avantika S; Scherl, Alexis; Wu, Thomas D; Patil, Namrata S; de Almeida, Patricia; Kadel Iii, Edward E; Madireddi, Shravan; Au-Yeung, Amelia; Takahashi, Chikara; Chen, Ying-Jiun; Modrusan, Zora; McBride, Jacqueline; Nersesian, Rhea; El-Gabry, Ehab A; Robida, Mark D; Hung, Jeffrey C; Kowanetz, Marcin; Zou, Wei; McCleland, Mark; Caplazi, Patrick; Eshgi, Shadi Toghi; Koeppen, Hartmut; Hegde, Priti S; Mellman, Ira; Mathews, W Rodney; Powles, Thomas; Mariathasan, Sanjeev; Grogan, Jane; O'Gorman, William E

Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment

在接受阿特珠单抗治疗的非小细胞肺癌患者外周血中,晚期分化效应新抗原特异性CD8+ T细胞富集。

Fehlings, Michael; Jhunjhunwala, Suchit; Kowanetz, Marcin; O'Gorman, William E; Hegde, Priti S; Sumatoh, Hermi; Lee, Boon Heng; Nardin, Alessandra; Becht, Etienne; Flynn, Susan; Ballinger, Marcus; Newell, Evan W; Yadav, Mahesh

Immune profiles in primary squamous cell carcinoma of the head and neck

头颈部原发性鳞状细胞癌的免疫特征

Saloura, Vassiliki; Izumchenko, Evgeny; Zuo, Zhixiang; Bao, Riyue; Korzinkin, Michael; Ozerov, Ivan; Zhavoronkov, Alex; Sidransky, David; Bedi, Atul; Hoque, Mohammad O; Koeppen, Hartmut; Keck, Michaela K; Khattri, Arun; London, Nyall; Kotlov, Nikita; Fatima, Aiman; Vougiouklakis, Theodore; Nakamura, Yusuke; Lingen, Mark; Agrawal, Nishant; Savage, Peter A; Kron, Stephen; Kline, Justin; Kowanetz, Marcin; Seiwert, Tanguy Y

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC

FIR:一项针对PD-L1阳性非小细胞肺癌患者的阿特珠单抗II期开放标签研究的疗效、安全性和生物标志物分析

Spigel, David R; Chaft, Jamie E; Gettinger, Scott; Chao, Bo H; Dirix, Luc; Schmid, Peter; Chow, Laura Q M; Hicks, Rodney J; Leon, Larry; Fredrickson, Jill; Kowanetz, Marcin; Sandler, Alan; Funke, Roel; Rizvi, Naiyer A

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)

非小细胞肺癌中免疫细胞和肿瘤细胞对PD-L1表达的差异性调控及其对阿特珠单抗(抗PD-L1)治疗的反应

Kowanetz, Marcin; Zou, Wei; Gettinger, Scott N; Koeppen, Hartmut; Kockx, Mark; Schmid, Peter; Kadel, Edward E 3rd; Wistuba, Ignacio; Chaft, Jamie; Rizvi, Naiyer A; Spigel, David R; Spira, Alexander; Hirsch, Fred R; Cohen, Victor; Smith, Dustin; Boyd, Zach; Miley, Natasha; Flynn, Susan; Leveque, Vincent; Shames, David S; Ballinger, Marcus; Mocci, Simonetta; Shankar, Geetha; Funke, Roel; Hampton, Garret; Sandler, Alan; Amler, Lukas; Mellman, Ira; Chen, Daniel S; Hegde, Priti S

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

阿特珠单抗对比多西他赛治疗既往接受过治疗的非小细胞肺癌患者(OAK):一项3期、开放标签、多中心随机对照试验

Rittmeyer, Achim; Barlesi, Fabrice; Waterkamp, Daniel; Park, Keunchil; Ciardiello, Fortunato; von Pawel, Joachim; Gadgeel, Shirish M; Hida, Toyoaki; Kowalski, Dariusz M; Dols, Manuel Cobo; Cortinovis, Diego L; Leach, Joseph; Polikoff, Jonathan; Barrios, Carlos; Kabbinavar, Fairooz; Frontera, Osvaldo Arén; De Marinis, Filippo; Turna, Hande; Lee, Jong-Seok; Ballinger, Marcus; Kowanetz, Marcin; He, Pei; Chen, Daniel S; Sandler, Alan; Gandara, David R

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)

Atezolizumab 作为一线或后续疗法治疗程序性死亡配体 1 选择的晚期非小细胞肺癌患者的 II 期试验 (BIRCH)

Peters, Solange; Gettinger, Scott; Johnson, Melissa L; Jänne, Pasi A; Garassino, Marina C; Christoph, Daniel; Toh, Chee Keong; Rizvi, Naiyer A; Chaft, Jamie E; Carcereny Costa, Enric; Patel, Jyoti D; Chow, Laura Q M; Koczywas, Marianna; Ho, Cheryl; Früh, Martin; van den Heuvel, Michel; Rothenstein, Jeffrey; Reck, Martin; Paz-Ares, Luis; Shepherd, Frances A; Kurata, Takayasu; Li, Zhengrong; Qiu, Jiaheng; Kowanetz, Marcin; Mocci, Simonetta; Shankar, Geetha; Sandler, Alan; Felip, Enriqueta

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

代谢物分析将胰腺导管腺癌分为对代谢抑制剂具有不同敏感性的亚型

Anneleen Daemen, David Peterson, Nisebita Sahu, Ron McCord, Xiangnan Du, Bonnie Liu, Katarzyna Kowanetz, Rebecca Hong, John Moffat, Min Gao, Aaron Boudreau, Rana Mroue, Laura Corson, Thomas O'Brien, Jing Qing, Deepak Sampath, Mark Merchant, Robert Yauch, Gerard Manning, Jeffrey Settleman, Georgia Ha

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

癌症患者对抗 PD-L1 抗体 MPDL3280A 反应的预测相关性

Roy S Herbst, Jean-Charles Soria, Marcin Kowanetz, Gregg D Fine, Omid Hamid, Michael S Gordon, Jeffery A Sosman, David F McDermott, John D Powderly, Scott N Gettinger, Holbrook E K Kohrt, Leora Horn, Donald P Lawrence, Sandra Rost, Maya Leabman, Yuanyuan Xiao, Ahmad Mokatrin, Hartmut Koeppen, Priti

Bone marrow-derived progenitor cells attenuate inflammation in lipopolysaccharide-induced acute respiratory distress syndrome

骨髓来源的祖细胞可减轻脂多糖诱导的急性呼吸窘迫综合征的炎症反应。

Rafat, Neysan; Dacho, Christine; Kowanetz, Gregor; Betzen, Christian; Tönshoff, Burkhard; Yard, Benito; Beck, Grietje